Nevirapine: Biovirapine is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1-infection.
Dosage and Administration:
one 200 mg tablet daily (4 mg/kg/day in pediatric patients) for the first 14 days (lead-in) followed by one 200 mg tablet twice daily (4 or 7 mg/kg twice daily, according to age, for pediatric patients).
- Dermatologic:Rash (grade 1 and 2, 13.3%; grade 3 and 4, 1.5%)
- Gastrointestinal:Diarrhea (37% to 41% ), Nausea (20% to 38%)
- Neurologic: Fatigue, Headache